Computer software for the identification and analysis of neoepitopes that control tumors in vivo; software platforms for processing cancer and normal protein sets, identifying high-quality patient-specific neoepitopes, and designing personalized cancer vaccines; bioinformatics software for predicting the immunogenicity of neoepitopes and aiding in the design of targeted cancer therapies